Kevin O'Brien;Laura Knoll;Stacey L. Schultz-Cherry;Lori Neal
发明人:
Stacey L. Schultz-Cherry,Laura Knoll,Lori Neal,Kevin O'Brien,Kevin OBrien
申请号：
US13386784
公开号：
US20120189581A1
申请日:
2010.07.23
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention provides a composition comprising an amount of a live attenuated or avirulent Toxoplasma gondii strain or a soluble extract thereof or a soluble extract of a wild-type T. gondii strain effective to inhibit or prevent heterologous microbial pathogen infection or replication, or one or more symptoms or manifestations of the microbial pathogen infection or replication, and methods of making or using the compositions.
